These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 26222205)

  • 1. Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.
    Papais-Alvarenga RM; Vasconcelos CC; Carra A; de Castillo IS; Florentin S; Diaz de Bedoya FH; Mandler R; de Siervi LC; Pimentel ML; Alvarenga MP; Alvarenga MP; Grzesiuk AK; Gama Pereira AB; Gomes Neto AP; Velasquez C; Soublette C; Fleitas CV; Diniz DS; Armas E; Batista E; Hernandez F; Pereira FF; Siqueira HH; Cabeça H; Sanchez J; Brooks JB; Gonçalves MV; Barroso MC; Ravelo ME; Castillo MC; Ferreira ML; Rocha MS; Parolin MK; Molina O; Marinho PB; Christo PP; Brant de Souza R; Pessanha Neto S; Camargo SM; Machado SC; Neri VC; Fragoso YD; Alvarenga H; Thuler LC
    PLoS One; 2015; 10(7):e0127757. PubMed ID: 26222205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?
    Papais Alvarenga RM; Araújo ACRAE; Nascimento ACB; Araujo NEC; Meneguette NS; Neri VC; Papais Alvarenga M; Filho HA; Barros PO; Bento CA; Schmidt SL; Vasconcelos CCF; Alvarenga MP
    Mult Scler Relat Disord; 2020 Jul; 42():102082. PubMed ID: 32361664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.
    Papais-Alvarenga RM; Vasconcelos CC; Alves-Leon SV; Batista E; Santos CM; Camargo SM; Godoy M; Lacativa MC; Lorenti M; Damasceno B; Damasceno A; Brum D; Barreira AA; Guimarães Rocha MS; Alvarenga H; Tilbery CP
    Mult Scler; 2014 Mar; 20(3):374-81. PubMed ID: 23970504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
    Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
    Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial forms of multiple sclerosis and neuromyelitis optica at an MS center in Rio de Janeiro State, Brazil.
    Papais-Alvarenga RM; Pereira FF; Bernardes MS; Papais-Alvarenga M; Batista E; Paiva CA; Santos CM; Vasconcelos CC
    J Neurol Sci; 2015 Sep; 356(1-2):196-201. PubMed ID: 26115914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
    Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
    Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
    Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
    Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
    Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
    Altintas A; Karabudak R; Balci BP; Terzi M; Soysal A; Saip S; Tuncer Kurne A; Uygunoglu U; Nalbantoglu M; Gozubatik Celik G; Isik N; Celik Y; Gokcay F; Duman T; Boz C; Yucesan C; Mangan MS; Celebisoy N; Diker S; Colpak Isikay I; Kansu T; Siva A
    Neurologist; 2015 Oct; 20(4):61-6. PubMed ID: 26468870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.
    Juryńczyk M; Weinshenker B; Akman-Demir G; Asgari N; Barnes D; Boggild M; Chaudhuri A; D'hooghe M; Evangelou N; Geraldes R; Illes Z; Jacob A; Kim HJ; Kleiter I; Levy M; Marignier R; McGuigan C; Murray K; Nakashima I; Pandit L; Paul F; Pittock S; Selmaj K; de Sèze J; Siva A; Tanasescu R; Vukusic S; Wingerchuk D; Wren D; Leite I; Palace J
    J Neurol; 2016 Jan; 263(1):140-9. PubMed ID: 26530512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMO spectrum disorders comprise the major portion of CNS inflammatory diseases in Thai patients: A cross sectional study.
    Apiwattanakul M; Kasemsuk C
    Mult Scler Relat Disord; 2014 Jan; 3(1):61-6. PubMed ID: 25877974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis.
    Mealy MA; Wingerchuk DM; Greenberg BM; Levy M
    Arch Neurol; 2012 Sep; 69(9):1176-80. PubMed ID: 22733096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of neuromyelitis optica.
    Wingerchuk DM
    Neurologist; 2007 Jan; 13(1):2-11. PubMed ID: 17215722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
    Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
    JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of Latin American patients.
    Carnero Contentti E; Soto de Castillo I; Daccach Marques V; López PA; Antunes Barreira A; Armas E; de Aquino Cruz C; Rubstein A; Lavigne Moreira C; Molina OM; Soto A; Tkachuk V
    Mult Scler Relat Disord; 2018 Feb; 20():109-114. PubMed ID: 29367170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
    Yang Y; Wu WP; Huang DH; Wu L
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
    Chitnis T; Ness J; Krupp L; Waubant E; Hunt T; Olsen CS; Rodriguez M; Lotze T; Gorman M; Benson L; Belman A; Weinstock-Guttman B; Aaen G; Graves J; Patterson M; Rose JW; Casper TC
    Neurology; 2016 Jan; 86(3):245-52. PubMed ID: 26683648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overlapping CNS inflammatory diseases: differentiating features of NMO and MS.
    Juryńczyk M; Craner M; Palace J
    J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):20-5. PubMed ID: 25248365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic inflammatory demyelinating disorders after acute transverse myelitis.
    Chan KH; Tsang KL; Fong GC; Ho SL; Cheung RT; Mak W
    Eur J Neurol; 2006 Aug; 13(8):862-8. PubMed ID: 16879297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital].
    Vaknin-Dembinsky A; Levin N; Raz N; Abramsky O; Karussis D; Brill L; Petrou P; Ovadia H
    Harefuah; 2013 Feb; 152(2):101-5, 122. PubMed ID: 23513502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.